Different nucleobase orientations in two cyclic 2′,3′‐phosphates of purine ribonucleosides: Et3NH(2′,3′‐cAMP) and Et3NH(2′,3′‐cGMP)·H2O

The crystal structures of triethyl­ammonium adenosine cyclic 2′,3′‐phosphate {systematic name: triethyl­ammonium 4‐(6‐amino­purin‐9‐yl)‐6‐hydroxy­methyl‐2‐oxido‐2‐oxoperhydro­furano[3,4‐c][1,3,2]dioxaphosphole}, Et₃NH(2′,3′‐cAMP) or C₆H₁₆N⁺·C₁₀H₁₁N₅O₆P⁻, (I), and guanosine cyclic 2′,3′‐phosphate monohydrate {systematic name: triethyl­ammonium 6‐hydroxy­methyl‐2‐oxido‐2‐oxo‐4‐(6‐oxo‐1,6‐dihydro­purin‐9‐yl)perhydro­furano[3,4‐c][1,3,2]dioxaphosphole monohydrate}, [Et₃NH(2′,3′‐cGMP)]·H₂O or C₆H₁₆N⁺·C₁₀H₁₁N₅O₇P⁻·H₂O, (II), reveal different nucleobase orientations, viz. anti in (I) and syn in (II). These are stabilized by different inter‐ and intra­molecular hydrogen bonds. The structures also exhibit different ribose ring puckering [₄E in (I) and ³T₂ in (II)] and slightly different 1,3,2‐dioxaphospho­lane ring conformations, viz. envelope in (I) and puckered in (II). Infinite ribbons of 2′,3′‐cAMP⁻ and helical chains of 2′,3′‐cGMP⁻ ions, both formed by O—H⋯O, N—H⋯X and C—H⋯X (X = O or N) hydrogen‐bond contacts, characterize (I) and (II), respectively.     

The first 3′:5′‐cyclic nucleotide–amino acid complex: l‐His–cIMP

In the crystal structure of the l ‐His–cIMP complex, i.e.l ‐histidinium inosine 3′:5′‐cyclic phosphate [systematic name: 5‐(2‐amino‐2‐carboxyethyl)‐1H‐imidazol‐3‐ium 7‐hydroxy‐2‐oxo‐6‐(6‐oxo‐6,9‐dihydro‐1H‐purin‐9‐yl)‐4a,6,7,7a‐tetrahydro‐4H‐1,3,5,2λ⁵‐furo[3,2‐d][1,3,2λ⁵]dioxaphosphinin‐2‐olate], C₆H₁₀N₃O₂⁺·C₁₀H₁₀N₄O₇P⁻, the Hoogsteen edge of the hypoxanthine (Hyp) base of cIMP and the Hyp face are engaged in specific amino acid–nucleotide (His...cIMP) recognition, i.e. by abutting edge‐to‐edge and by π–π stacking, respectively. The Watson–Crick edge of Hyp and the cIMP phosphate group play a role in nonspecific His...cIMP contacts. The interactions between the cIMP anions (anti/C3′–endo/trans–gauche/chair conformers) are realized mainly between riboses and phosphate groups. The results for this l ‐His–cIMP complex, compared with those for the previously reported solvated l ‐His–IMP crystal structure, indicate a different nature of amino acid–nucleotide recognition and interactions upon the 3′:5′‐cyclization of the nucleotide phosphate group.     

Luminescence properties of three structures built from 3‐cyano‐4‐dicyanomethylene‐5‐oxo‐4,5‐dihydro‐1H‐pyrrol‐2‐olate and alkaline metals (Na,K and Rb)

The structures of three salts of 3‐cyano‐4‐dicyanomethylene‐5‐oxo‐4,5‐dihydro‐1H‐pyrrol‐2‐olate with alkali metals (Na, K and Rb) are related to their luminescence properties. The Rb salt, rubidium(I) 3‐cyano‐4‐dicyanomethylene‐5‐oxo‐4,5‐dihydro‐1H‐pyrrol‐2‐olate, Rb⁺·C₈HN₄O₂⁻, is isomorphous with the previously reported potassium salt. For the Na compound, sodium(I) 3‐cyano‐4‐dicyanomethylene‐5‐oxo‐4,5‐dihydro‐1H‐pyrrol‐2‐olate dihydrate, Na⁺·C₈HN₄O₂⁻·2H₂O, two independent sodium ions, located on inversion centers, are coordinated by four water molecules each and additionally by two cyano groups for one and two carbonyl groups for the other. The luminescence spectra in solution are unaffected by the nature of the cation but vary strongly with the dielectric constant of the solvent. In the solid state, the emission maxima vary with structural features; the redshift of the maximum luminescence varies inversely with the distance between the stacked anions.     

3′:5′‐Cyclic nucleotides: two sodium salts of cdTMP

3′:5′‐Cyclic nucleotides play an outstanding role in signal transduction at the cellular level but, in spite of comprehensive knowledge of the biological role of cyclic nucleotides, their structures are not established fully. Two hydrated sodium salts of thymidine 3′:5′‐cyclic phosphate (cdTMP, C₁₀H₁₂N₂O₇P), namely sodium thymidine 3′:5′‐cyclic phosphate heptahydrate, Na⁺·C₁₀H₁₂N₂O₇P⁻·7H₂O or Na(cdTMP)·7H₂O, (I), and sodium thymidine 3′:5′‐cyclic phosphate 3.7‐hydrate, Na⁺·C₁₀H₁₂N₂O₇P⁻·3.7H₂O or Na(cdTMP)·3.7H₂O, (II), have been obtained in crystalline form and structurally characterized, revealing one nucleotide in the asymmetric unit of (I) and eight different nucleotides in (II). All the cyclic nucleotide anions adopt a similar conformation with regard to nucleobase orientation, sugar conformation and 1,3,2‐dioxaphosphorinane ring puckering. In (I), no direct inter‐nucleotide hydrogen bonds are present, and adjacent nucleotide anions interact via water‐mediated and Na⁺‐mediated contacts. In contrast, in (II), direct thymine–phosphate N—H...O inter‐nucleotide hydrogen bonds occur and these are assisted by numerous inter‐nucleotide C—H...O contacts, giving rise to the self‐assembly of cdTMP⁻ anions into three different ribbons. Two of these three ribbons run in the same direction, while the third is antiparallel.     

Purine 3′:5′‐cyclic nucleotides with the nucleobase in a syn orientation: cAMP,cGMP and cIMP

Purine 3′:5′‐cyclic nucleotides are very well known for their role as the secondary messengers in hormone action and cellular signal transduction. Nonetheless, their solid‐state conformational details still require investigation. Five crystals containing purine 3′:5′‐cyclic nucleotides have been obtained and structurally characterized, namely adenosine 3′:5′‐cyclic phosphate dihydrate, C₁₀H₁₂N₅O₆P·2H₂O or cAMP·2H₂O, (I), adenosine 3′:5′‐cyclic phosphate 0.3‐hydrate, C₁₀H₁₂N₅O₆P·0.3H₂O or cAMP·0.3H₂O, (II), guanosine 3′:5′‐cyclic phosphate pentahydrate, C₁₀H₁₂N₅O₇P·5H₂O or cGMP·5H₂O, (III), sodium guanosine 3′:5′‐cyclic phosphate tetrahydrate, Na⁺·C₁₀H₁₁N₅O₇P⁻·4H₂O or Na(cGMP)·4H₂O, (IV), and sodium inosine 3′:5′‐cyclic phosphate tetrahydrate, Na⁺·C₁₀H₁₀N₄O₇P⁻·4H₂O or Na(cIMP)·4H₂O, (V). Most of the cyclic nucleotide zwitterions/anions [two from four cAMP present in total in (I) and (II), cGMP in (III), cGMP⁻ in (IV) and cIMP⁻ in (V)] are syn conformers about the N‐glycosidic bond, and this nucleobase arrangement is accompanied by C_rib—H…N_pur hydrogen bonds (rib = ribose and pur = purine). The base orientation is tuned by the ribose pucker. An analysis of data obtained from the Cambridge Structural Database made in the context of syn–anti conformational preferences has revealed that among the syn conformers of various purine nucleotides, cyclic nucleotides and dinucleotides predominate significantly. The interactions stabilizing the syn conformation have been indicated. The inter‐nucleotide contacts in (I)–(V) have been systematized in terms of the chemical groups involved. All five structures display three‐dimensional hydrogen‐bonded networks.     

3‐Cyano‐6‐hydroxy‐4‐methyl‐2‐pyridone: two new pseudopolymorphs and two cocrystals with products of an in situ nucleophilic aromatic substitution

Four crystal structures of 3‐cyano‐6‐hydroxy‐4‐methyl‐2‐pyridone (CMP), viz. the dimethyl sulfoxide monosolvate, C₇H₆N₂O₂·C₂H₆OS, (1), the N,N‐dimethylacetamide monosolvate, C₇H₆N₂O₂·C₄H₉NO, (2), a cocrystal with 2‐amino‐4‐dimethylamino‐6‐methylpyrimidine (as the salt 2‐amino‐4‐dimethylamino‐6‐methylpyrimidin‐1‐ium 5‐cyano‐4‐methyl‐6‐oxo‐1,6‐dihydropyridin‐2‐olate), C₇H₁₃N₄⁺·C₇H₅N₂O₂⁻, (3), and a cocrystal with N,N‐dimethylacetamide and 4,6‐diamino‐2‐dimethylamino‐1,3,5‐triazine [as the solvated salt 2,6‐diamino‐4‐dimethylamino‐1,3,5‐triazin‐1‐ium 5‐cyano‐4‐methyl‐6‐oxo‐1,6‐dihydropyridin‐2‐olate–N,N‐dimethylacetamide (1/1)], C₅H₁₁N₆⁺·C₇H₅N₂O₂⁻·C₄H₉NO, (4), are reported. Solvates (1) and (2) both contain the hydroxy group in a para position with respect to the cyano group of CMP, acting as a hydrogen‐bond donor and leading to rather similar packing motifs. In cocrystals (3) and (4), hydrolysis of the solvent molecules occurs and an in situ nucleophilic aromatic substitution of a Cl atom with a dimethylamino group has taken place. Within all four structures, an R₂²(8) N—H...O hydrogen‐bonding pattern is observed, connecting the CMP molecules, but the pattern differs depending on which O atom participates in the motif, either the ortho or para O atom with respect to the cyano group. Solvents and coformers are attached to these arrangements via single‐point O—H...O interactions in (1) and (2) or by additional R₄⁴(16) hydrogen‐bonding patterns in (3) and (4). Since the in situ nucleophilic aromatic substitution of the coformers occurs, the possible Watson–Crick C–G base‐pair‐like arrangement is inhibited, yet the cyano group of the CMP molecules participates in hydrogen bonds with their coformers, influencing the crystal packing to form chains.     

Supramolecular hydrogen‐bonded networks in cytosinium nicotinate monohydrate and cytosinium isonicotinate cytosine dihydrate

The title compounds are proton‐transfer compounds of cytosine with nicotinic acid [systematic name: 4‐amino‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium nicotinate monohydrate (cytosinium nicotinate hydrate), C₄H₆N₃O⁺·C₆H₄NO₂⁻·H₂O, (I)] and isonicotinic acid [systematic name: 4‐amino‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium isonicotinate–4‐aminopyrimidin‐2(1H)‐one–water (1/1/2) (cytosinium isonicotinate cytosine dihydrate), C₄H₆N₃O⁺·C₆H₄NO₂⁻·C₄H₅N₃O·2H₂O, (II)]. In (I), the cation and anion are interlinked by N—H...O hydrogen bonding to form a one‐dimensional tape. These tapes are linked through water molecules to form discrete double sheets. In (II), the cytosinium–cytosine base pairs are connected by triple hydrogen bonds, leading to one‐dimensional polymeric ribbons. These ribbons are further interconnected via nicotinate–water and water–water hydrogen bonding, resulting in an overall three‐dimensional network.     

Cationic,neutral and anionic metal(II) complexes derived from 4‐oxo‐4H‐pyran‐2,6‐dicarboxylic acid (chelidonic acid)

The structures of five metal complexes containing the 4‐oxo‐4H‐pyran‐2,6‐dicarboxylate dianion illustrate the remarkable coordinating versatility of this ligand and the great structural diversity of its complexes. In tetraaquaberyllium 4‐oxo‐4H‐pyran‐2,6‐dicarboxylate, [Be(H₂O)₄](C₇H₂O₆), (I), the ions are linked by eight independent O—H...O hydrogen bonds to form a three‐dimensional hydrogen‐bonded framework structure. Each of the ions in hydrazinium(2+) diaqua(4‐oxo‐4H‐pyran‐2,6‐dicarboxylato)calcate, (N₂H₆)[Ca(C₇H₂O₆)₂(H₂O)₂], (II), lies on a twofold rotation axis in the space group P2/c; the anions form hydrogen‐bonded sheets which are linked into a three‐dimensional framework by the cations. In bis(μ‐4‐oxo‐4H‐pyran‐2,6‐dicarboxylato)bis[tetraaquamanganese(II)] tetrahydrate, [Mn₂(C₇H₂O₆)₂(H₂O)₈]·4H₂O, (III), the metal ions and the organic ligands form a cyclic centrosymmetric Mn₂(C₇H₂O₆)₂ unit, and these units are linked into a complex three‐dimensional framework structure containing 12 independent O—H...O hydrogen bonds. There are two independent Cu^II ions in tetraaqua(4‐oxo‐4H‐pyran‐2,6‐dicarboxylato)copper(II), [Cu(C₇H₂O₆)(H₂O)₄], (IV), and both lie on centres of inversion in the space group P; the metal ions and the organic ligands form a one‐dimensional coordination polymer, and the polymer chains are linked into a three‐dimensional framework containing eight independent O—H...O hydrogen bonds. Diaqua(4‐oxo‐4H‐pyran‐2,6‐dicarboxylato)cadmium monohydrate, [Cd(C₇H₂O₆)(H₂O)₂]·H₂O, (V), forms a three‐dimensional coordination polymer in which the organic ligand is coordinated to four different Cd sites, and this polymer is interwoven with a complex three‐dimensional framework built from O—H...O hydrogen bonds.     

4‐Aminopyridinium 2‐(anthracen‐9‐yl)‐3‐oxo‐3H‐inden‐1‐olate monohydrate

The title compound, 2C₅H₇N₂⁺·2C₂₃H₁₃O₂⁻·H₂O, formed as a by‐product in the attempted synthesis of a nonlinear optical candidate molecule, contains two independent 4‐aminopyridinium cations and 2‐(anthracen‐9‐yl)‐3‐oxo‐3H‐inden‐1‐olate anions with one solvent water molecule. This is the first reported structure containing these anions. The two anions are not planar, having different interplanar angles between the anthracenyl and inden‐1‐olate moieties of 59.07 (5) and 83.92 (5)°. The crystal packing, which involves strong classical hydrogen bonds and one C—H...π interaction, appears to account for both the nonplanarity and this difference.     

Statistically disordered short hydrogen bonds in (pipzH2)(cdoH)2 and a comparison with (pipzH2)(cdo)·H2O (pipz is piperazine and cdoH2 is chelidonic acid)

Two related proton‐transfer compounds, namely piperazine‐1,4‐diium 4‐oxo‐4H‐pyran‐2,6‐dicarboxylate monohydrate, C₄H₁₂N₂²⁺·C₇H₂O₆²⁻·H₂O or (pipzH₂)(cdo)·H₂O, (I), and piperazine‐1,4‐diium bis(6‐carboxy‐4‐oxo‐4H‐pyran‐2‐carboxylate), C₄H₁₂N₂²⁺·2C₇H₃O₆⁻ or (pipzH₂)(cdoH)₂, (II), were obtained by the reaction of 4‐oxo‐4H‐pyran‐2,6‐dicarboxylic acid (chelidonic acid, cdoH₂) and piperazine (pipz). In (I), both carboxyl H atoms of chelidonic acid have been transferred to piperazine to form the piperazine‐1,4‐diium ion. The structure is a monohydrate. All potential N—H donors are involved in N—H...O hydrogen bonds. The water molecule spans two anions via the 4‐oxo group of the pyranose ring and a carboxylate O atom. The hydrogen‐bonding motif is essentially two‐dimensional. The structure is a pseudomerohedral twin. In the asymmetric unit of (II), the anion consists of monodeprotonated chelidonic acid, while the piperazine‐1,4‐diium cation is located on an inversion centre. The single carboxyl H atom is disordered in two respects. Firstly, the disordered H atom is shared equally by both carboxylic acid groups. Secondly, the H atom is statistically disordered between two positions on either side of a centre of symmetry and is engaged in a very short hydrogen‐bonding interaction; the relevant O...O distances are 2.4549 (11) and 2.4395 (11) Å, and the O—H...O angles are 177 (6) and 177 (5)°, respectively. Further hydrogen bonding of the type N—H...O places the (pipzH₂)²⁺ cations in pockets formed by the chains of (cdoH)⁻ anions. In contrast with (I), the (pipzH₂)²⁺ cations form hydrogen‐bonding arrays that are perpendicular to the anions, yielding a three‐dimensional hydrogen‐bonding motif. The structures of both (I) and (II) also feature π–π stacking interactions between aromatic rings.     

Impact of the anion and chalcogen on the crystal structure and properties of 4,6‐dimethyl‐2‐pyrimido(thio)nium halides

By the reaction of urea or thiourea, acetylacetone and hydrogen halide (HF, HBr or HI), we have obtained seven new 4,6‐dimethyl‐2‐pyrimido(thio)nium salts, which were characterized by single‐crystal X‐ray diffraction, namely, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium bifluoride, C₆H₉N₂O⁺·HF₂^? or (dmpH)F₂H, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium bromide, C₆H₉N₂O⁺·Br^? or (dmpH)Br, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium iodide, C₆H₉N₂O⁺·I^? or (dmpH)I, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium iodide–urea (1/1), C₆H₉N₂O⁺·I^?·CH₄N₂O or (dmpH)I·ur, 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium bifluoride–thiourea (1/1), C₆H₉N₂S⁺·HF₂^?·CH₄N₂S or (dmptH)F₂H·tu, 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium bromide, C₆H₉N₂S⁺·Br^? or (dmptH)Br, and 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium iodide, C₆H₉N₂S⁺·I^? or (dmptH)I. Three HCl derivatives were described previously in the literature, namely, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium chloride, (dmpH)Cl, 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium chloride monohydrate, (dmptH)Cl·H₂O, and 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium chloride–thiourea (1/1), (dmptH)Cl·tu. Structural analysis shows that in 9 out of 10 of these compounds, the ions form one‐dimensional chains or ribbons stabilized by hydrogen bonds. Only in one compound are parallel planes present. In all the structures, there are charge‐assisted N⁺—H…X^? hydrogen bonds, as well as weaker C_Ar⁺—H…X^? and π⁺…X^? interactions. The structures can be divided into five types according to their hydrogen‐bond patterns. All the compounds undergo thermal decomposition at relatively high temperatures (150–300 °C) without melting. Four oxopyrimidinium salts containing a π⁺…X^?…π⁺ sandwich‐like structural motif exhibit luminescent properties.     

Two monosodium salt hydrates of Colour Index Pigment Red 48

We report herein the crystal structures of a monohydrate of Colour Index Pigment Red 48 (P.R.48) (systematic name: monosodium 2‐{2‐[3‐carboxy‐2‐oxo‐1,2‐dihydronaphthalen‐1‐ylidene]hydrazin‐1‐yl}‐4‐chloro‐5‐methylbenzenesulfonate monohydrate), Na⁺·C₁₈H₁₂ClO₆S^?·H₂O, and a dihydrate, Na⁺·C₁₈H₁₂ClO₆S^?·2H₂O. The two monosodium salt hydrates of P.R.48 were obtained from in‐house synthesized P.R.48. Both have monoclinic (P2₁/c) symmetry at 173 K. The crystal packing of both crystal structures shows a layer arrangement whereby N—H…O and O—H…O hydrogen bonds are formed.     

A new route for the synthesis of phosphate esters: 2,2′‐[benzene‐1,2‐diylbis(oxy)]bis(5,5‐dimethyl‐1,3,2‐dioxaphosphinane) 2,2′‐dioxide

Podand‐type ligands are an interesting class of acyclic ligands which can form host–guest complexes with many transition metals and can undergo conformational changes. Organic phosphates are components of many biological molecules. A new route for the synthesis of phosphate esters with a retained six‐membered ring has been used to prepare 2,2′‐[benzene‐1,2‐diylbis(oxy)]bis(5,5‐dimethyl‐1,3,2‐dioxaphosphinane) 2,2′‐dioxide, C₆H₄{O[cyclo‐P(O)OCH₂CMe₂CH₂O]}₂ or C₁₆H₂₄O₈P₂, (1), 2‐[(2′‐hydroxybiphenyl‐2‐yl)oxy]‐5,5‐dimethyl‐1,3,2‐dioxaphosphinane 2‐oxide, [cyclo‐P(O)OCH₂CMe₂CH₂O](2,2′‐OC₆H₄–C₆H₄OH), (2), and oxybis(5,5‐dimethyl‐1,3,2‐dioxaphosphinane) 2,2′‐dioxide, O[cyclo‐P(O)OCH₂CMe₂CH₂O]₂, (3). Compound (1) is novel, whereas the results for compounds (2) and (3) have been reported previously, but we record here our results for compound (3), which we find are more precise and accurate than those currently reported in the literature. In (1), two cyclo‐P(O)OCH₂CMe₂CH₂O groups are linked through a catechol group. The conformations about the two catechol O atoms are quite different, viz. one C—C—O—P torsion angle is −169.11 (11)° and indicates a trans arrangement, whereas the other C—C—O—P torsion angle is 92.48 (16)°, showing a gauche conformation. Both six‐membered POCCCO rings have good chair‐shape conformations. In both the trans and gauche conformations, the catechol O atoms are in the axial sites and the short P=O bonds are equatorially bound.     

Hydrogen bonding in 1:1 proton‐transfer compounds of 5‐sulfosalicylic acid with 4‐X‐substituted anilines (X = F,Cl or Br)

The crystal structures of three proton‐transfer compounds of 5‐sulfosalicylic acid (3‐carboxy‐4‐hydroxy­benzene­sulfonic acid) with 4‐X‐substituted anilines (X = F, Cl and Br), namely 4‐fluoro­anilinium 5‐sulfosalicylate (3‐carboxy‐4‐hydroxybenzenesulfonate) monohydrate, C₆H₇FN⁺·C₇H₅O₆S⁻·H₂O, (I), 4‐chloro­anilinium 5‐sulfosalicylate hemihydrate, C₆H₇ClN⁺·C₇H₅O₆S⁻·0.5H₂O, (II), and 4‐bromo­anilinium 5‐sulfosalicylate monohydrate, C₆H₇BrN⁺·C₇H₅O₆S⁻·H₂O, (III), have been determined. The asymmetric unit in (II) contains two formula units. All three compounds have three‐dimensional hydrogen‐bonded polymeric structures in which both the water molecule and the carboxylic acid group are involved in structure extension. With both (II) and (III), which are structurally similar, the common cyclic (8) dimeric carboxylic acid association is present, whereas in (I), an unusual cyclic (8) association involving all three hetero‐species is found.     

Three oxo complexes with a tetra­nuclear [Cu4(μ2‐Cl)6(μ4‐O)] unit

The three title compounds, namely 4‐phenyl‐1H‐imidazolium hexa‐μ₂‐chloro‐chloro‐μ₄‐oxo‐tris­(4‐phenyl‐1H‐imidazole‐κN¹)­tetra­copper(II) monohydrate, (C₉H₉N₂)[Cu₄Cl₇O(C₉H₈N₂)₃]·H₂O, hexa‐μ₂‐chloro‐μ₄‐oxo‐tetra­kis­(pyridine N‐oxide‐κO)tetra­copper(II), [Cu₄Cl₆O(C₅H₅NO)₄], and hexa‐μ₂‐chloro‐tetra­kis(2‐methyl‐1H‐imidazole‐κN¹)‐μ₄‐oxo‐tetra­copper(II) methanol trisolvate, [Cu₄Cl₆O(C₄H₆N₂)₄]·3CH₄O, exhibit the same Cu₄OCl₆ framework, where the O atom at the centre of an almost regular tetra­hedron bridges four copper cations at the corners. This group is in turn surrounded by a Cl₆ octa­hedron, leading to a rather globular species. This special arrangement of the Cu^II cations results in a diversity of magnetic behaviours.     

A three‐dimensional manganese(II) metal–organic framework based on 5‐methoxybenzene‐1,3‐dicarboxylic acid and exhibiting a pts net

The solvothermal reaction of MnCl₂·H₂O and 5‐methoxybenzene‐1,3‐dicarboxylic acid (MeO‐m‐H₂BDC) led to a three‐dimensional Mn^II metal–organic framework, namely poly[(dimethylformamide‐κO)(μ₄‐5‐methoxybenzene‐1,3‐dicarboxylato‐κ⁴O¹:O^1′:O³,O^3′:O³)manganese(II)], [Mn(C₉H₆O₅)(C₃H₇NO)]_n or [Mn(MeO‐m‐BDC)(DMF)]_n (DMF is dimethylformamide). The Mn^II atom is six‐coordinated and exhibits a distorted octahedral geometry formed by five carboxylate O atoms from four different MeO‐m‐BDC²⁻ anionic ligands and by one DMF O atom. The three‐dimensional framework of (I) formed by the bridging MeO‐m‐BDC²⁻ ligands and the Mn^II atoms exhibits a pts topological network when MeO‐m‐BDC²⁻ and Mn^II are viewed as four‐connected nodes.     

6‐Chloroisocytosine and 5‐bromo‐6‐methylisocytosine: again,one or two tautomers present in the same crystal?

It is well known that pyrimidin‐4‐one derivatives are able to adopt either the 1H‐ or the 3H‐tautomeric form in (co)crystals, depending on the coformer. As part of ongoing research to investigate the preferred hydrogen‐bonding patterns of active pharmaceutical ingredients and their model systems, 2‐amino‐6‐chloropyrimidin‐4‐one and 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4‐one have been cocrystallized with several coformers and with each other. Since Cl and Br atoms both have versatile possibilities to interact with the coformers, such as via hydrogen or halogen bonds, their behaviour within the crystal packing was also of interest. The experiments yielded five crystal structures, namely 2‐aminopyridin‐1‐ium 2‐amino‐6‐chloro‐4‐oxo‐4H‐pyrimidin‐3‐ide–2‐amino‐6‐chloropyrimidin‐4(3H)‐one (1/3), C₅H₇N₂⁺·C₄H₃ClN₃O⁻·3C₄H₄ClN₃O, (Ia), 2‐aminopyridin‐1‐ium 2‐amino‐6‐chloro‐4‐oxo‐4H‐pyrimidin‐3‐ide–2‐amino‐6‐chloropyrimidin‐4(3H)‐one–2‐aminopyridine (2/10/1), 2C₅H₇N₂⁺·2C₄H₃ClN₃O⁻·10C₄H₄ClN₃O·C₅H₆N₂, (Ib), the solvent‐free cocrystal 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one (1/1), C₅H₆BrN₃O·C₅H₆BrN₃O, (II), the solvate 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one–N‐methylpyrrolidin‐2‐one (1/1/1), C₅H₆BrN₃O·C₅H₆BrN₃O·C₅H₉NO, (III), and the partial cocrystal 2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐5‐bromo‐6‐methylpyrimidin‐4(1H)‐one–2‐amino‐6‐chloropyrimidin‐4(3H)‐one (0.635/1/0.365), C₅H₆BrN₃O·C₅H₆BrN₃O·C₄H₄ClN₃O, (IV). All five structures show R₂²(8) hydrogen‐bond‐based patterns, either by synthon 2 or by synthon 3, which are related to the Watson–Crick base pairs.     

Two oxo complexes with tetra­nuclear [Fe4(μ3‐O)2]8+ and trinuclear [Fe3(μ3‐O)]7+ units

Two new oxo complexes, namely hexa‐μ₂‐acetato‐acetato­aquabis­(di‐3‐pyridylamine)di‐μ₃‐oxo‐tetra­iron(III) chloride mono­hydrate ethanol 1.25‐solvate, [Fe₄(C₂H₃O₂)₇O₂(C₁₀H₉N₃)₂(H₂O)]Cl·1.25C₂H₆O·H₂O, (I), containing a tetra­nuclear [Fe₄(μ₃‐O)₂]⁸⁺ unit, and 2‐methyl­imidazolium hexa‐μ₂‐acetato‐acetatodiaqua‐μ₃‐oxo‐triiron(III) chloride dihydrate, (C₄H₇N₂)[Fe₃(C₂H₃O₂)₇O(H₂O)₂]Cl·2H₂O, (II), with a trinuclear [Fe₃(μ₃‐O)]⁷⁺ unit, are presented. Both structures are formed by two well differentiated entities, viz. a compact isolated cluster composed of Fe^III ions coordinated to O²⁻ and CH₃CO₂⁻ anions, and an external group formed by a central Cl⁻ ion surrounded by different solvent groups to which the anion is bound through hydrogen bonding. In the case of (I), charge balance cannot be achieved within the groups, so the structure is macroscopically ionic; in the case of (II), in contrast, each group is locally neutral owing to the inter­nal compensation of charges. The trinuclear complex crystallizes with the metal cluster, chloride anion and 2‐methyl­imidazolium cation bisected by a crystallographic mirror plane.     

A novel copper(II) complex with 1,10‐phenanthroline and ciprofloxacin

The X‐ray structure analysis of the title compound, chloro[1‐cyclopropyl‐6‐fluoro‐1,4‐dihydro‐4‐oxo‐7‐(piperazin‐4‐ium‐1‐yl)‐3‐quinolinecarboxylate‐κ²O³,O⁴](1,10‐phenanthroline‐κ²N,N′)copper chloride dihydrate, [CuCl(C₁₇H₁₈FN₃O₃)(C₁₂H₈N₂)]Cl·2H₂O or [CuCl(cfH)(phen)]Cl·2H₂O, where cfH is 1‐cyclopropyl‐6‐fluoro‐1,4‐dihydro‐4‐oxo‐7‐(piperazin‐4‐ium‐1‐yl)‐3‐quinolinecarboxylate and phen is 1,10‐phenanthroline, shows that the geometry around the Cu ion is a slightly distorted square pyramid. Two O atoms of the carbonyl and carboxyl groups of ciprofloxacin and two N atoms of 1,10‐phenanthroline are coordinated to the metal centre in the equatorial plane, and a Cl⁻ ion is coordinated at the apical position. Extensive intermolecular hydrogen bonding produces a supramolecular structure that consists of alternating six‐ and 12‐membered rings.     

Crystal structures of deprotonated nucleobases from an expanded DNA alphabet

Reported here is the crystal structure of a heterocycle that implements a donor–donor–acceptor hydrogen‐bonding pattern, as found in the Z component [6‐amino‐5‐nitropyridin‐2(1H)‐one] of an artificially expanded genetic information system (AEGIS). AEGIS is a new form of DNA from synthetic biology that has six replicable nucleotides, rather than the four found in natural DNA. Remarkably, Z crystallizes from water as a 1:1 complex of its neutral and deprotonated forms, and forms a `skinny' pyrimidine–pyrimidine pair in this structure. The pair resembles the known intercalated cytosine pair. The formation of the same pair in two different salts, namely poly[[aqua(μ₆‐2‐amino‐6‐oxo‐3‐nitro‐1,6‐dihydropyridin‐1‐ido)sodium]–6‐amino‐5‐nitropyridin‐2(1H)‐one–water (1/1/1)], denoted Z‐Sod, {[Na(C₅H₄N₃O₃)(H₂O)]·C₅H₅N₃O₃·H₂O}_n, and ammonium 2‐amino‐6‐oxo‐3‐nitro‐1,6‐dihydropyridin‐1‐ide–6‐amino‐5‐nitropyridin‐2(1H)‐one–water (1/1/1), denoted Z‐Am, NH₄⁺·C₅H₄N₃O₃⁻·C₅H₅N₃O₃·H₂O, under two different crystallization conditions suggests that the pair is especially stable. Implications of this structure for the use of this heterocycle in artificial DNA are discussed.